Ede-Golightly James 4
4 · Silence Therapeutics plc · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Ede-Golightly James
Director
Transactions
- Award
Share Option (Right to Buy)
2025-01-02+48,000→ 48,000 totalExercise: $2.40Exp: 2035-01-02→ Ordinary Shares (48,000 underlying)
Footnotes (1)
- [F1]This option shall vest in equal monthly installments over a three-year period measured from one month following January 2, 2025, subject to the Reporting Person's continuous service as of each applicable vesting date.